|
MMWR Early Release
Vol. 66, Early Release
July 07, 2017
PDF
In this report
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
Lucy A. McNamara, PhD; Nadav Topaz, MSc; Xin Wang, PhD; et al.
Sixteen cases of meningococcal disease were identified in eculizumab recipients in the United States for the period 2008–2016.
MMWR Masthead
Stay up-to-date with the "voice of CDC" by downloading the MMWR Express app for fast access to MMWR:
https://www.cdc.gov/mmwr/mmwr_mobileapps.html.
Department of Health and Human Services
Centers for Disease Control and Prevention
| This email was sent to list-cdc@xxxxxxxxxxx using GovDelivery Communications Cloud on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636) |
 |
|
